J&J Could Explore Potential $2B Sale of Sterilization Products Division Post author:Sam Post published:February 19, 2018 Post category:BioPharma Life sciences giant Johnson & Johnson may be shopping around its sterilization products division. Source: BioSpace You Might Also Like Amgen-Backed Immatics Lands $58 Million To Develop T-Cell Receptor Based Immunotherapies October 3, 2017 Corning, Merck & Co. and Pfizer to Invest $4 Billion and Create 4,000 New Jobs in the U.S. July 20, 2017 AzurRx BioPharma and Mayoly Spindler Announce MS1819-SD Investigational Medicinal Product Dossier… October 19, 2017
Amgen-Backed Immatics Lands $58 Million To Develop T-Cell Receptor Based Immunotherapies October 3, 2017
Corning, Merck & Co. and Pfizer to Invest $4 Billion and Create 4,000 New Jobs in the U.S. July 20, 2017
AzurRx BioPharma and Mayoly Spindler Announce MS1819-SD Investigational Medicinal Product Dossier… October 19, 2017